The combination treatment of Botulinum toxin and ablative fractional CO2 lasering to prevent scar formation after thyroidectomy and removal of neck mass

Not Applicable

• Conditions: Endocrine, nutritional and metabolic diseases

• Registration Number: KCT0006396
• Lead Sponsor: The Catholic University of Korea, St. Vincent's Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 August 2021

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 75

Inclusion Criteria

Participant who is scheduled to undergo thyroid or tumor in neck through a cervical skin incision, and who heard the explanation of this clinical trial, voluntarily decided to participate and sign it.

Exclusion Criteria

- Children under 19 years old / Seniors over 75 years old
- Pregnant or planning to become pregnant within 6 months, lactating women
- When it is expected that regular follow-up cannot be performed
- No surgery after consent or other surgery (robot surgery or endoscopy)
surgery)
- Myasthenia gravis or peripheral motor nervous system disease
- If had radiation therapy before
- If external radiation is planned after surgery
- If the scheduled operation is a reoperation in the same area
- When a drainage tube is inserted into the skin incision (in case of incision drainage due to deep cervical infection, etc.)
- If known to have keloid
- If allergic to botulinum toxin

Study & Design

• Study Type: Interventional Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Vancouver scar scale (VSS)

Secondary Outcome Measures

Name	Time	Method
Global assessment score (GAS)